1、根据实验需要选择合适的溶剂配制储备液 (母液)：对于大多数产品，InvivoChem推荐用DMSO配置母液 (比如：5、10、20mM或者10、20、50 mg/mL浓度），个别水溶性高的产品可直接溶于水。产品在DMSO 、水或其他溶剂中的具体溶解度详见上”溶解度 (体外)”部分;
2、如果您找不到您想要的溶解度信息，或者很难将产品溶解在溶液中，请联系我们;
3、建议使用下列计算器进行相关计算（摩尔浓度计算器、稀释计算器、分子量计算器、重组计算器等）;
4、母液配好之后，将其分装到常规用量，并储存在-20°C或-80°C，尽量减少反复冻融循环。
A 'Screen and Treat' Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile
CTID: NCT05926804
Phase: N/A Status: Recruiting
Date: 2024-11-18
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
CTID: NCT04551963
Phase: Phase 1 Status: Completed
Date: 2024-10-26
Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin
CTID: NCT06551623
Phase: Phase 1 Status: Completed
Date: 2024-10-24
A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
CTID: NCT04630145
Phase: Phase 2/Phase 3 Status: Active, not recruiting
Date: 2024-10-24
Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)
CTID: NCT06294600
Phase: Phase 3 Status: Recruiting
Date: 2024-10-23
View More
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma
CTID: NCT01559935
Phase: Phase 2 Status: Active, not recruiting
Date: 2024-09-26
Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma
CTID: NCT02542657
Phase: Phase 1/Phase 2 Status: Active, not recruiting
Date: 2024-09-19
Selinexor and Backbone Treatments of Multiple Myeloma Patients
CTID: NCT02343042
Phase: Phase 1/Phase 2 Status: Recruiting
Date: 2024-09-19
Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.
CTID: NCT06603688
Phase: Phase 4 Status: Recruiting
Date: 2024-09-19
7 Days Vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication
CTID: NCT06576882
Phase: Phase 3 Status: Active, not recruiting
Date: 2024-08-30
Vonoprazan for Helicobacter Pylori Eradication in Adolescents
CTID: NCT06162949
Phase: Phase 3 Status: Completed
Date: 2024-08-28
Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
CTID: NCT00836706
Phase: Phase 1 Status: Completed
Date: 2024-08-20
Clarithromycin 500 mg Tablets Under Fasting Conditions
CTID: NCT00835692
Phase: Phase 1 Status: Completed
Date: 2024-08-20
The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)
CTID: NCT05845567
Phase: Phase 1 Status: Completed
Date: 2024-08-16
Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication
CTID: NCT06168214
Phase: Phase 4 Status: Recruiting
Date: 2024-08-13
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
CTID: NCT06523764
Phase: Phase 4 Status: Not yet recruiting
Date: 2024-07-30
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
CTID: NCT06396078
Phase: Phase 4 Status: Recruiting
Date: 2024-07-29
Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication
CTID: NCT06514274
Phase: Phase 4 Status: Not yet recruiting
Date: 2024-07-23
Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
CTID: NCT01745588
Phase: Phase 2 Status: Active, not recruiting
Date: 2024-07-03
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
CTID: NCT04302324
Phase: Phase 2 Status: Recruiting
Date: 2024-06-26
Clarithromycin Mechanisms in Hypersomnia Syndromes
CTID: NCT04026958
Phase: Phase 2 Status: Recruiting
Date: 2024-06-20
Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection
CTID: NCT06250634
Phase: N/A Status: Completed
Date: 2024-05-29
Comparative Bioavailability Study of Clarithromycin 250 mg Tablets
CTID: NCT00648830
Phase: Phase 1 Status: Completed
Date: 2024-04-24
Efficacy and Safety of Rifasutenizol (TNP 2198) in Participants With H. Pylori Infection
CTID: NCT05857163
Phase: Phase 3 Status: Completed
Date: 2024-04-02
A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants
CTID: NCT06227832
Phase: Phase 1 Status: Active, not recruiting
Date: 2024-03-27
Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians
CTID: NCT06315478
Phase: Phase 4 Status: Completed
Date: 2024-03-18
Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection
CTID: NCT06216639
Phase: Status: Enrolling by invitation
Date: 2024-02-09
Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults
CTID: NCT05991401
Phase: Phase 1 Status: Completed
Date: 2024-01-25
Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
CTID: NCT04724044
Phase: Phase 3 Status: Completed
Date: 2023-12-12
A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants
CTID: NCT05965570
Phase: Phase 1 Status: Completed
Date: 2023-12-11
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
CTID: NCT05742568
Phase: Phase 4 Status: Recruiting
Date: 2023-11-14
Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients
CTID: NCT04843579
Phase: Phase 2 Status: Terminated
Date: 2023-10-25
A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection
CTID: NCT04198363
Phase: Phase 3 Status: Completed
Date: 2023-09-07
A Study of Vonoprazan in Adults With Helicobacter Pylori
CTID: NCT04753437
Phase: Phase 1 Status: Completed
Date: 2023-08-31
The Observation on the Efficacy of Dual Therapy Based on Vonoprazan in Eradicating Helicobacter Pylori
CTID: NCT06004401
Phase: N/A Status: Not yet recruiting
Date: 2023-08-22
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
CTID: NCT04310930
Phase: Phase 2/Phase 3 Status: Recruiting
Date: 2023-08-08
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
CTID: NCT05049902
Phase: Phase 4 Status: Completed
Date: 2023-07-19
Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin
CTID: NCT05915871
Phase: Phase 1 Status: Completed
Date: 2023-06-23
Electrophysiological Effects of Potential QT Prolonging Drugs
CTID: NCT05716854
Phase: Phase 1 Status: Completed
Date: 2023-06-22
BiRd vs. Rd as Initial Therapy in Multiple Myeloma
CTID: NCT02516696
Phase: Phase 3 Status: Terminated
Date: 2023-06-05
Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children
CTID: NCT05861687
Phase: Phase 2/Phase 3 Status: Completed
Date: 2023-05-17
Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
CTID: NCT05718609
Phase: Phase 4 Status: Recruiting
Date: 2023-05-15
CYP3A4 Activity and Mineral Homeostasis
CTID: NCT02019875
PhaseEarly Phase 1 Status: Completed
Date: 2023-04-19
CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
CTID: NCT03236987
Phase: Phase 3 Status: Recruiting
Date: 2023-03-22
Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection
CTID: NCT05419674
Phase: Phase 4 Status: Unknown status
Date: 2023-02-16
High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population
CTID: NCT05342532
Phase: Phase 4 Status: Completed
Date: 2023-02-01
Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy
CTID: NCT04697186
Phase: Phase 4 Status: Completed
Date: 2023-01-31
Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication
CTID: NCT05014334
Phase: Phase 4 Status: Completed
Date: 2023-01-31
Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
CTID: NCT03440112
Phase: Phase 1/Phase 2 Status: Completed
Date: 2023-01-10
A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
CTID: NCT05469126
Phase: Phase 1 Status: Completed
Date: 2022-11-25
Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community
CTID: NCT03824847
Phase: Phase 4 Status: Suspended
Date: 2022-11-04
Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male Volunteers
CTID: NCT03366974
Phase: Phase 1 Status: Completed
Date: 2022-10-27
Evaluation of Metabolic Markers for the Prediction of DDI of Various CYP3A Substrates and Inhibitors
CTID: NCT02975037
Phase: Phase 1 Status: Completed
Date: 2022-10-27
Vonoprazan Hp Dual or Triple Eradication Regimes
CTID: NCT05345210
Phase: Phase 4 Status: Unknown status
Date: 2022-10-20
Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity
CTID: NCT05492318
Phase: Phase 1 Status: Completed
Date: 2022-08-08
Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment
CTID: NCT05152004
Phase: N/A Status: Completed
Date: 2022-07-20
S. Aureus Decolonization in HPN Patients.
CTID: NCT03173053
Phase: N/A Status: Terminated
Date: 2022-05-31
Duration of Antibiotics Treatment With Cefazoli
ANTIBIOTIC THERAPY IN RESPIRATORY TRACT INFECTIONS: AIR.
CTID: null
Phase: Phase 4 Status: Trial now transitioned
Date: 2020-04-03
Prospective randomised trial of first line treatments of Helicobacter pylori infection in Slovenia
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2020-03-09
Shortened Antibiotic Treatment in Community-Acquired Pneumonia: A Nationwide Danish Randomized Controlled Trial
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2019-04-29
An Open Label Study to Assess the Efficacy and Safety of Fixed-Dose
CTID: null
Phase: Phase 3 Status: Prematurely Ended
Date: 2019-02-14
Effects of antibiotics on micobiota, pulmonary immune response and incidence of ventilator-associated infections
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2019-01-14
Defining best Management in Adult Chronic RhinOsinusitis
CTID: null
Phase: Phase 4 Status: GB - no longer in EU/EEA
Date: 2018-07-13
Immediate oral, immediate topical or delayed oral antibiotics for acute otitis media with discharge (the Runny Ear STudy: REST)
CTID: null
Phase: Phase 4 Status: Completed
Date: 2018-05-23
CLArithromycin versus AZIthromycin in the treatment of Mycobacterium avium complex pulmonary infections:
CTID: null
Phase: Phase 3 Status: Trial now transitioned
Date: 2017-09-15
A randomized, double-blind, placebo-controlled study of the usefulness of the probiotic 'Lactobacillus reuteri' in the therapy of quadruple eradication of Helicobacter pylori infection in usual clinical practice
CTID: null
Phase: Phase 4 Status: Completed
Date: 2017-04-04
Placebo-kontrollierte, multizentrische, randomisierte, doppelblinde Phase III-Studie zur Verbesserung der gastrointestinalen Verträglichkeit einer per-oralen Antibiotikatherapie durch add-on-Gabe von Lactobacillus rhamnosus GG (InfectoDiarrstop® LGG® Mono Kapseln) bezogen auf die Häufigkeit einer AAD bei Kindern unter 2 Jahren
CTID: null
Phase: Phase 3 Status: Prematurely Ended
Date: 2016-11-17
A phase II trial addressing feasibility and activity of clarithromycin +
CTID: null
Phase: Phase 2 Status: Ongoing
Date: 2016-08-31
Eradication of H. pylori infection in Belgium: bismuth versus first line therapy
CTID: null
Phase: Phase 4 Status: Completed
Date: 2016-07-13
Biomarker guided antibiotic treatment in Community-Acquired Pneumoni (BIO-CAP)
CTID: null
Phase: Phase 4 Status: Completed
Date: 2016-04-01
Lenalidomide and dexamethasone (Ld) versus Clarithromycin / Lenalidomide [Revlimid®] / Dexamethasone (BiRd) as initial therapy in Multiple Myeloma.
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2015-09-30
Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia (COVID-19)
CTID: null
Phase: Phase 4 Status: Trial now transitioned, Temporarily Halted, GB - no longer in EU/EEA, Ongoing
Date: 2015-09-16
A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately Active Crohn’s Disease
CTID: null
Phase: Phase 3 Status: Prematurely Ended
Date: 2015-08-27
A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease
CTID: null
Phase: Phase 3 Status: Completed
Date: 2015-07-24
insulin resistance, obesity and gastrointestinal bacteria
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2015-06-09
A randomized placebo-controlled phase II study of clarithromycin or placebo
CTID: null
Phase: Phase 2 Status: Prematurely Ended
Date: 2014-09-05
A randomized, open-label phase III study of Clarithromycin, Sulfamethoxa-zole/Trimethoprim or observation in combination with standard therapy in patients with newly diagnosed multiple myeloma
CTID: null
Phase: Phase 3 Status: Completed
Date: 2013-01-29
FIRST-LINE ERADICATOR THERAPY OF HELICOBACTER PYLORI INFECTION: OPEN CLINICAL TRIAL, RANDOMIZED, MULTICENTRE, THREE-ARMED, COMPARING THE CLASSICAL TRIPLE THERAPY VERSUS A MODIFIED SEQUENTIAL THERAPY AND A CURRENT THERAPY
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2012-04-02
Individualizing duration of antibiotic therapy in hospitalized patients with community-acquired pneumonia: a non-inferiority, randomized, controlled trial.
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2011-12-20
Helicobacter eradication to prevent ulcer bleeding in aspirin users: a large simple randomised controlled trial
CTID: null
Phase: Phase 4 Status: GB - no longer in EU/EEA
Date: 2011-12-15
Phase II clinical study on the activity of salvage therapy with high doses of oral clarithromycin in patients with extranodal marginal zone relapsed or refractory lymphoma
CTID: null
Phase: Phase 2 Status: Ongoing
Date: 2011-12-06
The pharmacokinetic effect of clarithromycin on the AUC0-12h of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients
CTID: null
Phase: Phase 1, Phase 4 Status: Ongoing
Date: 2011-07-27
A prospective single blind randomised controlled study to compare the outcomes of patients with diabetes and clinically non-infected ischaemic and neuropathic foot ulcers treated with and without oral antibiotics
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2011-07-13
A Phase II trial of broad spectrum antibiotic therapy for early stage chronic lymphocytic leukaemia.
CTID: null
Phase: Phase 4 Status: Completed
Date: 2011-03-24
ESTUDIO FASE IV, PROSPECTIVO, ALEATORIZADO Y COMPARATIVO ENTRE LA TERAPIA SECUENCIAL Y CONCOMITANTE PARA LA ERRADICACIÓN DE Helicobacter pylori EN LA PRÁCTICA CLÍNICA HABITUAL
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2010-09-22
PLEASE Persistent Lyme Empiric Antibiotic Study Europe. A prospective, randomised study comparing two prolonged oral antibiotic strategies after initial intravenous ceftriaxone therapy for patients with symptoms of proven or possible persistent Lyme disease
CTID: null
Phase: Phase 4 Status: Completed
Date: 2010-04-29
Ensayo clínico unicéntrico, simple ciego y aleatorizado de comparación de la eficacia erradicadora de primera línea frente al Helicobacter pylori entre la triple terapia convencional oral con claritromicina, amoxicilina y omeprazol (CAO) durante 10 días frente a triple terapia alternativa oral con levofloxacino, amoxicilina y omeprazol (LAO) durante 10 días
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2008-09-29
A cluster randomised trial of different strategies of antibiotic use to reduce the incidence and consequences of chest infection in acute stroke patients with swallowing problems.
CTID: null
Phase: Phase 4 Status: Completed
Date: 2008-08-13
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 days
CTID: null
Phase: Phase 3 Status: Completed
Date: 2008-03-28
Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 10 Days Versus Clarithromycin in the Treatment of Community-Acquired Pneumonia”
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2008-01-06
A national, prospective, randomized, open label study to asses the efficacy and safety of IV/PO moxifloxacin vs IV ceftriaxone + IV azithromicin followed by PO amoxicilline/clavulanate and PO claritromycin in subjects with community-acquired pneumonia
CTID: null
Phase: Phase 3 Status: Prematurely Ended
Date: 2007-12-10
Efficacité comparative de l'éradication de H.pylori et d'un inhibiteur de pompe à proton vs. l'abstention thérapeutique sur lésions gastriques induite par l'aspirine à faible dose chez les malades traités au long cours en prévention d'une thrombose coronaire ou vasculaire cérébrale-Aspylori.
CTID: null
Phase: Phase 4 Status: Ongoing
Date: 2007-11-09
Helicobacter pylori Eradication vs Aspirin Toxicity Trial
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2007-09-21
Does adding YF476 to amoxicillin and clarithromycin aid eradication of H. pylori from healthy carriers?
CTID: null
Phase: Phase 2 Status: Completed
Date: 2007-07-13
Helicobacter eradication therapy in Chronic Obstructive Pulmonary Disease: A pilot,randomised, double blinded, placebo controlled trial
CTID: null
Phase: Phase 4 Status: Completed
Date: 2007-06-22
A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL OF THE SAFETY AND IMMUNOMODULATORY THERAPY FOR THE MANAGEMENT OF SEPSIS
CTID: null
Phase: Phase 3 Status: Ongoing
Date: 2007-06-05
A Double-Blinded, Randomized, Parallel group, Multi-Centre, Multi-National Comparative Study of the Safety and Efficacy of Cethromycin 300mg QD to Clarithromycin (KLACID®) 250mg BID for the treatment of Community-Acquired Pneumonia (CAP) in Adults
CTID: null
Phase: Phase 3 Status: Completed
Date: 2006-08-24
Prospective, multicenter, randomized, double blind, parallel arm study to evaluate the efficacy and safety of Moxifloxacin 400 mg OD for 7 days versus amoxicillin clavulanate/claritromycin for 10 days in the treatment of Acute Bacterial Rhino Sinusitis
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2005-12-13
Untersuchung über die Empfindlichkeitsveränderungen oraler Mundstreptokokken gegenüber Makrolidantibiotika nach Gabe von AzithromycinSR versus ClarithromycinXL bei freiwilligen gesunden Probanden
CTID: null
Phase: Phase 2 Status: Ongoing
Date: 2005-08-31
Is there a role for Helicobacter pylori eradication in the treatment of laryngopharyngeal reflux? : A double blinded randomised case controlled clinical trial
CTID: null
Phase: Phase 4 Status: Prematurely Ended
Date: 2005-01-06
An Open-label, Randomised, Multicentre, Multi-country Three-arm Study of the Treatment with Finafloxacin 400 mg b.i.d. plus Esomeprazole 40 mg b.i.d. for 14 days versus Finafloxacin 400 mg b.i.d. plus Esomeprazole 40 mg b.i.d. plus Amoxicillin 1000 mg b.i.d. for 10 days versus Clarithromycin 500 mg b.i.d. plus Amoxicillin 1000 mg b.i.d. plus Esomeprazole 40 mg b.i.d. for 10 Days in Patients with Helicobacter pylori infection. Finafloxacin in patients with Helicobacter: The FLASH 2 Study
CTID: null
Phase: Phase 2 Status: Prematurely Ended, Completed
Date:
Long term follow up and comparative study of fecal microbiota after vonoprazan and low-dose amoxicillin dual therapy or vonoprazan-based triple therapy for Helicobacter pylori infection
CTID: UMIN000040025
Phase: Status: Complete: follow-up continuing
Date: 2020-04-01
Investigation of methods for preventing biofilm formation in peritoneal dialysis-related peritonitis
CTID: UMIN000038500
Phase: Status: Complete: follow-up complete
Date: 2019-11-11
Open-label randomized comparative study of ceftriaxone vs. ampicillin/sulbactam in adults with mild to moderate community-acquired pneumonia
CTID: UMIN000037464
Phase: Phase IV Status: Complete: follow-up complete
Date: 2019-07-25
Intermittent versus daily therapy for nodular bronchiectatic Mycobacterium avium complex lung disease (iREC)
CTID: jRCTs031190008
Phase: Status: Complete
Date: 2019-04-15
The Study on HElicobacter Pylori eradication in patients with HEPatic complications
CTID: UMIN000012196
Phase: Status: Complete: follow-up complete
Date: 2019-03-31
Antibacterial therapy for severe sarcoid uveitis
CTID: jRCTs031180301
Phase: Status: Complete
Date: 2019-03-15
Susceptibility based Fourth-line eradication
CTID: jRCTs031180208
Phase: Status: Complete
Date: 2019-03-07
Therapy with macrolide in severe asthmatic patients with peripheral blood neutrophilia: a non-blinded, crossover trial
CTID: UMIN000034699
Phase: Status: Pending
Date: 2018-11-02
Berberine containing therapy for initial Helicobacter Pylori eradication
CTID: UMIN000034554
Phase: Status: Recruiting
Date: 2018-10-20
Efficacy and safety of dual therapy containing vonopranzan and amoxicillin as first line Helicobacter pylori eradication: a randomized, non-inferiority trial
CTID: UMIN000034140
Phase: Phase II,III Status: Complete: follow-up complete
Date: 2018-09-14
Berberine containing quadruple therapy for initial Helicobacter Pylori eradication
CTID: UMIN000033829
Phase: Status: Recruiting
Date: 2018-08-20
Japanese AntibaCterial drug maNagemEnt for cardiac Sarcoidosis Trial
CTID: UMIN000025936
Phase: Status: Complete: follow-up continuing
Date: 2017-02-20
A pilot study of Susceptibility testing based Fourth-line Helicobacter pylori eradication therapy
CTID: UMIN000025765
Phase: Status: Complete: follow-up complete
Date: 2017-01-22
A randomized controlled trial comparing Vonoprazan, Amoxicillin and Metronidazole triple therapy and Vonoprazan, Amoxicillin and Clarithromycin triple therapy as a first-line eradication of Helicobacter pylori
CTID: UMIN000025773
Phase: Status: Complete: follow-up complete
Date: 2017-01-22
Establishment of the algorithm for reccurent infant wheezing under 2 years of age
CTID: UMIN000025243
PhaseNot applicable Status: Complete: follow-up complete
Date: 2017-01-04
Clarithromycin plus intravenous immunoglobulin therapy for Kawasaki disease, a phase 3, multicenter, randomized, double blind, placebo control study.
CTID: UMIN000024311
Phase: Status: Complete: follow-up complete
Date: 2016-10-06
Phase 2 study of clarithromycin, pomalidomide and dexamethasone(ClaPD) for patients with relapsed or refractory multiple myeloma
CTID: UMIN000024166
Phase: Phase II Status:
Date: 2016-09-26
Eradication of H. Pylori With the Regimen Individualized Susceptibility of H. Pylori to Clarithromycin Determined by the Mutation of 23S rRNA of H. Pylori
CTID: UMIN000022766
Phase: Phase II Status: Pending
Date: 2016-07-01
Comparison of vonoprazan-based dual therapy with amoxicillin and the triple therapy with amoxicillin and clarithromycin for H. Pylori Eradication
CTID: UMIN000022922
Phase: Status: Recruiting
Date: 2016-07-01
Prospective multicenter non-randomized parallel-group comparative study to evaluate the efficacy of P-CAB/AMPC/MNZ 7 day triple therapy as first line eradication of CAM-resistant Helicobacter pylori: superiority study compared to P-CAB/AMPC/CAM, non-inferiority study compared to PPI/AMPC/MNZ, superiority study compared to PPI/AMPC/CAM
CTID: UMIN000022920
Phase: Status: Complete: follow-up complete
Date: 2016-06-28
The efficacy and safety of Helicobacter pylori eradication therapy using vonoprazan
CTID: UMIN000021824
Phase: Status: Complete: follow-up complete
Date: 2016-04-07
Prospective multicenter cohort study to evaluate the efficacy and safety of Helicobacter pylori eradication therapy
CTID: UMIN000021604
Phase: Status: Complete: follow-up complete
Date: 2016-03-25
Investigation of improved Helicobacter pylori eradication rate using Vonoprazan for first-line therapy: large prospective study.
CTID: UMIN000021383
Phase: Status: Complete: follow-up complete
Date: 2016-03-07
A randomized controlled trial comparing the first-line eradication rate using vonoprazan or PPI for Helicobacter pylori infectious gastritis.
CTID: UMIN000021148
Phase: Status: Complete: follow-up complete
Date: 2016-02-23
Study of Helicobacter pylori eradication therapy using vonoprazan
CTID: UMIN000019158
Phase: Status: Complete: follow-up continuing
Date: 2015-10-01
Drug use surveillance of Takecab for 'Supplement to Helicobacter pylori eradication'
CTID: jRCT1080222951
Phase: Status:
Date: 2015-08-31
A trial to study of treatment with a new PPI for infection of H. pylori with Clarithromycin resistance
CTID: UMIN000018595
Phase: Status: Complete: follow-up continuing
Date: 2015-08-07
Investigation of the efficacy and safety of high-dose clarithromycin in adult patients with community-acquired pneumonia-multicenter,single-group,open-label study
CTID: UMIN000016277
Phase: Status: Complete: follow-up complete
Date: 2015-01-20
Study assessing combined therapy with clarithromycin and amoxicillin in childhood acute otitis media
CTID: UMIN000015564
Phase: Status: Complete: follow-up complete
Date: 2014-11-01
A multicenter, randomized control study to assess the safety and efficacy of IVIG plus clarithromycin, a biofilm modulator for Kawasaki disease.
CTID: UMIN000015437
Phase: Status: Complete: follow-up complete
Date: 2014-10-15
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea
CTID: UMIN000015375
Phase: Status: Complete: follow-up complete
Date: 2014-10-08
Phase 2 study to evaluate the efficacy and the safety of clarithromycin, lenalidomide and dexamethasone (Personalized BiRd) for patients with relapsed or refractory multiple myeloma
CTID: UMIN000013467
Phase: Phase II Status: Compllse if(down_display === 'none' || down_display === '') {
icon_angle_up.style.display = 'none';
icon_angle_down.style.displa
粤公网安备 44011102003439号
463611831
